Now Available for Research Use and Patient Testing

The VeraTag™ assay is a proximity-based method designed to detect and quantify proteins and protein-protein complexes, including homodimers and heterodimers of the EGFR-family of cell surface receptors.

An expanded panel of Quantitative Protein Assays now available for clinical development use. The HER1 and HER3 protein assays provide unique, quantitative measurements of protein expression and activity in formalin fixed paraffin embedded (FFPE) tumor samples. These assays supplement HERmark®, Monogram's HER2 Total and HER2 Homodimer Breast Cancer Assay, and expands the potential clinical reach of VeraTag assays to lung, colorectal and other cancers.